Skip to content

The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications

The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications and Intervention Measures - Prospective, Multicenter, Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05870449
Acronym
PICC
Enrollment
1666
Registered
2023-05-23
Start date
2023-07-01
Completion date
2024-12-31
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Infections, Phlebitis, Thrombus

Brief summary

In this study, eligible subjects were randomly assigned to the experimental or control group through randomization (1:1). Under the guidance of electrocardiographic Doppler ultrasound guided puncture and catheterization (EDUG) technology, the tunnel puncture method was compared with the conventional puncture method. The two groups of patients were observed and evaluated intraoperative and postoperative 7 ± 3 days, 30 ± 7 days, 60 ± 10 days, and 90 ± 10 days 120 ± 10 days (if any) and the occurrence of complications during extubation or unplanned extubation at the end of treatment, comparing cases in the north and south, as well as complications related to different catheterization methods

Interventions

Tunneled PICC is a type of PICC catheterization technique that involves establishing a subcutaneous tunnel to keep the outlet of the catheter away from the puncture site

DEVICEroutine PICC

Peripherally inserted central venous catheterization is a technique that involves inserting PICC through the peripheral vein and infusing drugs into the central vein through a catheter.

Sponsors

Hainan Cancer Hospital
CollaboratorOTHER
Shandong Branden Med.Device Co.,Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 18 years old; * Patients who follow medical advice and require PICC catheterization; * Patients who have not participated in other clinical studies; * Patients who voluntarily participate in this clinical study and can cooperate with clinical follow-up; * There are no serious cardiovascular diseases, such as atrial fibrillation, pulmonary heart disease, and other P-wave abnormalities before catheterization, as well as severe heart conduction block

Exclusion criteria

* Known allergies to catheter materials; * There is a history of infection, injury, and radiation therapy at the puncture site; * The puncture site has a history of venous thrombosis or surgery; * Severe abnormal coagulation function; * Superior vena cava compression syndrome; * Surgical side limbs of breast cancer patients undergoing radical mastectomy or axillary lymph node dissection; * Heart pacemaker and arteriovenous fistula on the same side of the limb; * Patients or patients' family members refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
rate of complications120 days after operation

Secondary

MeasureTime frame
time of catheter retention7, 30, 60, 90 and 120 days after operation

Other

MeasureTime frame
rate of unplanned extubation7, 30, 60, 90 and 120 days after operation
Success rate of one-time catheterization7, 30, 60, 90 and 120 days after operation
Operation timeImmediately after operation
incidence of difficulty in pulling out the tube7, 30, 60, 90 and 120 days after operation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026